10 research outputs found
Demographic and clinical characteristics of patients at baseline according to APOE genotype.
<p>Demographic and clinical characteristics of patients at baseline according to APOE genotype.</p
Kaplan–Meier estimates of the adverse events according to genotype.
<p>A) Major adverse cardiac events (MACE), B) Total peripheral revascularizations, C) Total deaths.</p
Hazard ratios for incident cardiovascular events.
<p>Hazard ratios for incident cardiovascular events.</p
Distribution of PTX3 levels in 704 AMI patients in relation to the time of blood collection.
<p>Blood samples were collected from 5 to 733 days after the AMI. This range was divided into tertiles: the first from 5 to 63 days, the second from 64 to 184 days and the third from 185 to 733 days. The mean PTX3 concentration was calculated for each tertile.</p
Distribution of rs2305619, rs3816527 and rs1840680 SNP genotypes in AMI patients and controls.
<p>Distribution of rs2305619, rs3816527 and rs1840680 SNP genotypes in AMI patients and controls.</p
Details of <i>PTX3</i> SNPs.
<p>HWE, Hardy-Weinberg Equilibrium test.</p><p>R<sup>2</sup>, Correlation coefficient.</p
Histograms of the mean PTX3 levels in AMI patients and controls in relation to genotype.
<p>Each graph shows the mean PTX3 levels (ng/mL), adjusted for sex and age, in AMI patients and controls according to rs2305619, rs3816527 and rs1840680 genotypes.</p
<i>PTX3</i> gene details. Gene map with position of SNPs typed and inter-marker distances.
<p><i>PTX3</i> gene details. Gene map with position of SNPs typed and inter-marker distances.</p
Main clinical characteristics of AMI patients and controls.
*<p>Wilcoxon rank sum test.</p>**<p>Chi-square test.</p>***<p>T-test.</p><p>IQR, Inter quartile range.</p